Childhood Cancer

You are here

Home » Grants » All grants tagged with "Medulloblastoma"

All grants tagged with "Medulloblastoma"

Role of Primary Cilium Signaling and Dynamics in Medulloblastoma Initiation and Progression
Saikat Mukhopadhyay, MD/PhD
University of Texas Southwestern Medical Center
'A' Award Grants, Awarded 2016
Circulating Exosomes as Biomarkers of Medulloblastoma Progression, Metastasis, and Recurrence
David Lyden, MD/PhD & Parveen Raju, MD/PhD
Weill Cornell Medical College
Innovation Grants, Awarded 2016
Pre-clinical Testing of Novel Glutamine Metabolic Inhibitors in MYC-driven Medulloblastoma
Eric Raabe, MD/PhD & Dr. Barbara Slusher, PhD
The Johns Hopkins University School of Medicine
Innovation Grants, Awarded 2016
Targeting Eya2 to Inhibit c-Myc driven Medulloblastoma Tumor Progression
Melanie Vincent, PhD
University of Colorado Denver
Young Investigator Grants, Awarded 2016
Control of Medulloblastoma through the Regulation of Tumor Debris
Megan Sulciner
Dana-Farber Cancer Institute
POST Program Grants, Awarded 2016
Site-specific Hyper-phosphorylation of IRF2BP2 Modulates Tumor PD-L1 Expression in Medulloblastoma
Daniel Kingsley
Case Western Reserve University
POST Program Grants, Awarded 2016
Histone H3.3 Targeted Therapy for Pediatric High-grade Gliomas
Paul Knoepfler, PhD
University of California, Davis Medical Center
Innovation Grants, Awarded 2015
Regulation of Tumor Debris Mediated Inflammation as a Therapeutic Modality in Medulloblastoma
Mark Kieran, MD, PhD & Dipak Panigrahy, MD
Dana-Farber Cancer Institute
Innovation Grants, Awarded 2015
Preclinical Development of Atr Inhibitor VE-822, Delivered Systemically in Nanoparticles, for Medulloblastoma Therapy
Timothy Gershon, MD, PhD
University of North Carolina
Innovation Grants, Awarded 2015
Characterizing Resistance Mechanisms to BET-Bromodomain Inhibition in MYC-amplified
Rameen Beroukhim, MD,PhD
Broad Institute
Innovation Grants, Awarded 2015

Pages

All childhood cancer types

Featured Hero

Ailani Myers

Ailani's family calls her a true Warrior Princess as she fights acute lymphoblastic leukemia. Doctors discovered Ailani harbored a rare genetic mutation which makes standard treatment ineffective. Today, Ailani has reached remission!
Read more »